Positron Corporation (POSC)
OTCMKTS · Delayed Price · Currency is USD
1.410
-0.040 (-2.76%)
Oct 7, 2025, 10:51 AM EDT
Positron Market Cap
Positron has a market cap or net worth of $45.54 million as of October 7, 2025. Its market cap has increased by 59.65% in one year.
Market Cap
45.54M
Enterprise Value
n/a
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.41
Market Cap Chart
Since December 3, 1993, Positron's market cap has increased from 22.73M to 45.54M, an increase of 100.34%. That is a compound annual growth rate of 2.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 45.54M | 65.12% |
| Dec 30, 2024 | 27.58M | -29.54% |
| Dec 29, 2023 | 39.14M | 88.62% |
| Dec 29, 2022 | 20.75M | -34.40% |
| Dec 31, 2021 | 31.63M | 1,169.21% |
| Dec 31, 2020 | 2.49M | 42.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |